Aristotle University Of Thessaloniki (AUTH)
Μελέτη της οξειδωτικής καταπόνησης ασθενών με σακχαρώδη διαβήτη τύπου ΙΙ και χρόνια αποφρακτική πνευμονοπάθεια
Abstract
dc:descriptionThe aim of our study was to indicate the quantitative differences of oxidative burden between a patient with stage I COPD and a patient with stage I COPD and DM II. As biomarkers of oxidative stress we used serum malonic dialdehyde (serum MDA) and serum carbonylated proteins (serum CP), registering lipid peroxidation and protein carbonylation. 158 people were studied. 32 didn’t suffer from any disease, 34 suffered from stage I COPD and 92 suffered from stage I COPD and DM II. The patients with diabetes mellitus were separated at first in three groups, according to the level of their HbA1c. The first group (30 patients) included diabetics with HbA1c lesser than 7%, the second group (31 patients) diabetics with HbA1c between 7% and 8% and the third group (31 patients) the diabetic patients with HbA1c higher than 8%. After registering the levels of s-MDA and s-CP of all the patients who were studied, we analyzed the results via the statistical method SPSS. This analysis demonstrated statistically significant differences at the levels of both oxidative stress biomarkers between patients with COPD and DM II (the highest levels of s-MDA and s-CP), patients with just COPD (lower levels than the previous group but higher than those without disease) and people with no disease (the lowest levels of s-MDA and s-CP of our study). As far as the 92 diabetic patients are concerned, we saw that those who had HbA1c>8% showed statistically significant increase of s-MDA and s-CP levels in comparison with the diabetics who had HbA1c between 7% and 8% and the diabetics who had HbA1c<7%. On the other hand, patients with HbA1c between 7% and 8% patients with HbA1c<7% didn’t appear with statistically significant differences neither at the levels of s-MDA nor at the levels of s-CP. Thus, all the diabetic patients with HbA1c<8%, were included in one group (61 patients) and a comparison was held concerning the levels of s-MDA and s-CP between this new group and the one with HbA1c>8%. The statistical analysis revealed statistically significant increase at the levels of both oxidative stress biomarkers in the group of HbA1c>8%. Final conclusions: a) A patient with stage I COPD and DM II suffers from more intense oxidative stress in comparison with a stage I COPD patient,. b) The HbA1c level which is considered as the margin of more intense oxidative stress at patients with stage I COPD and DM II is 8%, as indicated from the levels of serum MDA and the levels of serum CP. c) The intensity of oxidative alteration of proteins and lipids is increased simultaneously in both these two cell components as the oxidative burden increases. This conclusion derives from the fact that irrespective of the existing disease (just COPD or COPD and DM II), s-MDA and s-CP levels increase simultaneously according to the co-existence of COPD and DM II in comparison with just COPD, and the rising of HbA1c levels, presenting intensely positive correlation between them.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Keryttopoulos, Petros
- Κηρυττόπουλος, Πέτρος
Subjects
dc:subject × 14- Οξειδωτική καταπόνηση
- Σακχαρώδης διαβήτης τύπου ΙΙ
- Χρόνια αποφρακτική πνευμονοπάθεια (ΧΑΠ)
- Μαλονική διαλδεΰδη (MDA)
- Καρβονυλιωμένα παράγωγα
- Oxidative stress
- Diabetes mellitus type II
- Chronic obstructive pulmonary disease (COPD)
- Methylomalonic dialdehyde
- Carbonylated adducts
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27622